Cargando…
Oral immunotherapy for peanut allergy: The pro argument
Food allergy (FA) is a growing public health problem with personal, social, nutritional, and economic consequences. In the United States, it is estimated that 8% of children and 10.8% of adults have food allergies. Allergies to peanuts are particularly worrisome as unlike allergies to other allergen...
Autores principales: | Chinthrajah, R. Sharon, Cao, Shu, Dunham, Theresa, Sampath, Vanitha, Chandra, Sharad, Chen, Meng, Sindher, Sayantani, Nadeau, Kari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519204/ https://www.ncbi.nlm.nih.gov/pubmed/33005286 http://dx.doi.org/10.1016/j.waojou.2020.100455 |
Ejemplares similares
-
Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023) -
Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020) -
Shrimp‐allergic patients in a multi‐food oral immunotherapy trial
por: Nguyen, Diem‐Tran I., et al.
Publicado: (2021) -
Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study
por: Quake, Antonia Zoe, et al.
Publicado: (2022) -
Correction: Quake et al. Early Introduction of Multi-Allergen Mixture for Prevention of Food Allergy: Pilot Study. Nutrients 2022, 14, 737
por: Quake, Antonia Zoe, et al.
Publicado: (2022)